Previous close | 0.2300 |
Open | 0.2300 |
Bid | 0.0700 |
Ask | 0.3200 |
Strike | 47.50 |
Expiry date | 2025-01-17 |
Day's range | 0.2300 - 0.2300 |
Contract range | N/A |
Volume | |
Open interest | 111 |
AstraZeneca said on Tuesday it had initiated the worldwide withdrawal of its COVID-19 vaccine due to a "surplus of available updated vaccines" since the pandemic. The company also said it would proceed to withdraw the vaccine Vaxzevria's marketing authorizations within Europe. "As multiple, variant COVID-19 vaccines have since been developed there is a surplus of available updated vaccines," the company said, adding that this had led to a decline in demand for Vaxzevria, which is no longer being manufactured or supplied.
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Astrazeneca (AZN) have what it takes? Let's find out.